The ISPOR eBULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to: www.ispor.org. Please share these new ISPOR activities with your colleagues.
ISPOR 2010-2011 Board of Directors Call for Nominations
ISPOR is a member-driven organization. As a member-driven organization, its governance is determined by the membership. Since the Society is a diverse group with respect to education, work environment, geographic location, and type of outcomes research conducted (economic, patient-reported, or clinical [real world] outcomes) or use of outcomes research in health care decisions, the ISPOR Nominations Committee is seeking qualified candidates for the position of PRESIDENT-ELECT and 4 DIRECTOR positions to complement the incumbent Board members. For the 2009-2010 ISPOR Board of Directors members (including terms of office), see: http://www.ispor.org/board/index.asp. Please email your interest or recommendation to: email@example.com. Please attach curriculum vitae.
ISPOR 15th Annual International Meeting, Atlanta, GA, USA
The ISPOR 15th Annual International Meeting will be held May 15-19, 2010 at the Hilton Atlanta, Atlanta, GA, USA. For Plenary Session topics and sponsorship, exhibit, advertising and symposium opportunities, see:
ISPOR 15th Annual International Meeting »
ISPOR 4th Asia-Pacific Conference, Phuket, Thailand
The ISPOR 4th Asia-Pacific Conference will be held 5-7 September, 2010 at the Hilton Phuket, Phuket, Thailand. For sponsorship, exhibit, advertising and symposium opportunities, see:
ISPOR 4th Asia-Pacific Conference »
ISPOR 12th Annual European Congress, Paris, France
The ISPOR 12th Annual European Congress was held 24-27 October, 2009 at Le Palais des Congrès de Paris, Paris, France.
~RECORD HIGH ATTENDANCE - OVER 2700 REGISTRANTS TO DATE!~
The following Plenary Presentations can be found at:
12th European Congress Released Presentations »
FIRST PLENARY SESSION: Health Care Reimbursement Systems in Europe: Learning from Each Other
Speakers: Laurent Degos MD, PhD, Sir Michael Rawlins MD FRCP FMedSci, and Peter Sawicki MD, PhD
SECOND PLENARY SESSION: Performance-based Agreements - Theory to Practice
Speakers: Gérard de Pouvourville PhD, Sean D. Sullivan PhD, RPh, and Jens Grueger PhD
THIRD PLENARY SESSION: Involving Patients/Citizens in Health Care Decisions
Speakers: Victoria Thomas MSc, Nicola Bedlington, and Ulf Persson PhD
ISPOR 12th Annual European Congress Photos »
Best Research Podium and Poster Presentation Awards – 12th Annual European Congress Recipients
Research podium and poster presentation recipients (presenter photo as well as their presentation [PDF]) are now available at the ISPOR website. To view the awardees, go to:
Research Podium Presentation Recipients »
Research Poster Presentation Recipients »
ISPOR Scientific Awards
The Society’s awards are designed to recognize outstanding achievements in pharmacoeconomics and outcomes research. The ISPOR scientific awards are:
- ISPOR Avedis Donabedian Lifetime Achievement Award
- ISPOR Bernie J. O’Brien New Investigator Award
- ISPOR Award for Excellence in Methodology in Pharmacoeconomics and Health Outcomes Research
- ISPOR Award for Excellence in Application of Pharmacoeconomics and Health Outcomes Research
These ISPOR awards will be presented at the ISPOR 15th Annual International Meeting in Atlanta, GA, USA, May 15-19, 2010.
The ISPOR Awards Committee is now accepting nominations for all 4 awards. If you would like to nominate a candidate or yourself for one of the four awards, please send in the required nomination materials to: firstname.lastname@example.org by FRIDAY, FEBRUARY 12, 2010. Nomination requirements and detailed award descriptions can be found at the ISPOR website at:
ISPOR Scientific Achievement Awards »
ISPOR International Fellowship Award
ISPOR is seeking nominations for the 2010 International Fellowship Awards. The nominations deadline is November 30, 2009. Nominations can be sent to: email@example.com. For more information about this ISPOR award, see:
ISPOR International Fellowship Award »
NEW! Value in Health Early View Articles
64 Early View articles are available on-line, including 20 new articles added in the last month.
Value in Health Early View articles »
NEW! Value in Health Special Issue: Pharmacoeconomics and Outcomes Research in Asia
The Value in Health 2nd Special Issue: Pharmacoeconomics and Outcomes Research in Asia is now available on-line.
Value in Health Asia Special Issue »
NEW! Value in Health Volume 12, Issue 8 On-Line
Value in Health Volume 12, Issue 8 is now available on-line.
Value in Health Volume 12, Issue 8 »
NEW! ISPOR Venezuela Regional Chapter
The ISPOR Venezuela Regional Chapter will host its 2nd Venezuela Chapter Conference, 20-21 November 2009, Caracas, Venezuela.
For registration information and more details visit:
ISPOR Venezuela Regional Chapter »
NEW! ISPOR Poland Regional Chapter
The ISPOR Poland Regional Chapter will host its 7th Annual International Conference “Pharmacoeconomics in Anticrisis Management in Health Care,” December 1st – 2nd, 2009, Warsaw, Poland.
For registration information and more details visit:
ISPOR Poland Regional Chapter »
ISPOR SPECIAL INTEREST GROUPS/TASK FORCES/COMMITTEES
To join a Special Interest Group (SIG), see:
ISPOR Join Special Interest Group »
ISPOR Health Econometrics & Health Outcomes Statistics (HOM) Special Interest Group-CALL FOR MEMBERS
The goal of this new ISPOR SIG is to identify, highlight, and promote appropriate and novel approaches to health outcomes metrics [including health econometrics] used in pharmacoeconomics and outcomes research. For the HEALTH ECONOMETRICS SIG WORKING GROUP overview, objectives, and specific tasks, see: ISPOR Health Econometric Working Group.
ISPOR Risk Benefit Management (RBM) Special Interest Group-CALL FOR MEMBERS, REVIEWERS
The aim of the Risk Benefit Management Special Interest Group is to identify and describe the links between RBM and health outcomes research in public policy and health care decision-making to assure the safe and effective use of pharmaceutical products and devices. This Special Interest Group is currently working on several projects, including Risk Benefit Monitoring Worldwide, Direct to Consumer Advertising, a Head to Head Comparison of EMEA and US Guidelines, and a Comparison Across Industries of Risk Benefit Management Practices. If you would like to become involved in this SIG, see:
ISPOR RBM SIG »
ISPOR Health & Disease Management SIG-REQUEST FOR REVIEWERS
The ISPOR Health & Disease Management SIG is currently seeking reviewers for the first draft of their book, Reliability & Validity of Data Sources for Outcomes Research and Health & Disease Management. To review a section, (Claims, EMRs, Alternative Population Data Sources or Countries Around the World) please email: firstname.lastname@example.org. For more information and to see section outlines, go to:
ISPOR Health & Disease Management Special Interest Group »
ISPOR Patient Registry SIG-REQUEST FOR REVIEWERS
The Patient Registry Classification, Strategy & Design Working Group of the ISPOR Patient Registry Special Interest Group is seeking Section reviewers for their book, The ISPOR Taxonomy of Patient Registries: Classification, Characteristics & Terms for two book sections: the Analysis and Design, Development & Implementation sections. There is also the opportunity to participate as an author or co-author on several terms in these two sections. For more information on this book, go to:
ISPOR Books »
To review a section or to co-author terms in these sections, please email: email@example.com. For more information, go to:
ISPOR Patient Registry Special Interest Group »
Patient Registry Classification, Strategy & Design Working Group »
HTA of Medical Devices and Diagnostics Working Group
Two Working Teams were formed under the new HTA of Medical Device and Diagnostics Working Group of the HTA SIG: Diagnostics Team and Therapeutics Team. Their goal is to develop country-specific information on the health care reimbursement systems and decision-making processes for medical devices and diagnostics around the world.
For more information on this group, see:
ISPOR HTA of Medical Devices and Diagnostics Working Group »
Global Health Care Reimbursement Systems and Processes Working Group
The ISPOR Global Health Care systems Road Map provides country- specific information on health care reimbursement systems and decision making processes. Based on member’s feedback and contribution, it is constantly updated, modified and new countries are added. For more information, go to: ISPOR Global Health Care Reimbursement Systems and Decision Processes Working Group »
Send comments or suggestions on this ISPOR HTA initiative to: firstname.lastname@example.org
ISPOR CONSORTIUM NEWS
NEW! Indonesia National Seminar
The Indonesia National Seminar and Workshop on Health Economics: Patients and Pharmaceutical Use will take place at the Borobudur Hotel, Jakarta, Indonesia, 13-14 January 2010.
For details, visit: Upcoming ISPOR Asia-Pacific Conferences »
***************** Advertisements *********************
Career Opportunity in Patient Reported Outcomes
For more than 30 years, Genentech has been at the forefront of the biotechnology industry, using human genetic information to develop novel medicines for serious and life-threatening diseases. Today, Genentech is among the world's leading biotech companies, with multiple therapies on the market for cancer and other serious medical conditions.
The Global Development Division has an excellent opportunity for a Principal Patient Reported Outcomes. This position will maximize the value of multiple agents within a therapeutic area by leading and developing Patient Reported Outcome (PRO) strategies for molecules during early clinical development. Depending on the preference of the candidate, the position will be located in South San Francisco, CA, Nutley, NJ, Welwyn, England or Basel, Switzerland.
An advanced degree in Psychology, Epidemiology, Health Services Research, Outcomes Research or a related discipline is preferred. A minimum of five years of professional experience in PRO assessment and/or psychometric validation is required.
To learn more about this opportunity, please contact Robin Shaw at email@example.com or at 650-225-7918. Genentech is an equal opportunity employer.
***************** Advertisements *********************
TIP OF THE MONTH- ISPOR REGIONAL CHAPTERS
The first ISPOR Regional Chapter began in Russia in 1999. Since then, 31 Chapters in Asia, the Americas and Europe have been created to foster the application of pharmacoeconomics and health outcomes research in local decision-making processes. For more information on these dynamic groups, go to the ISPOR Regional Chapters link on the purple tool bar at the top of the ISPOR home page.
This newsletter is provided as a benefit of membership in
ISPOR. If you received this from a colleague and are not a current
ISPOR member, please consider becoming an
individual member or organizational affiliate. Contact membership
services for more information and its use in health care decisions.
The International Society for
Pharmacoeconomics and Outcomes Research is an international organization
promoting the science of pharmacoeconomics and health outcomes research.
3100 Princeton Pike, Suite 3E, Lawrenceville, NJ, 08648 USA
Toll Free: 1-800-992-0643 Fax: 609-219-0774